Short-term outcomes after heart transplantation using donor hearts preserved with ex vivo perfusion

References

• Khush KK, Cherikh WS, Chambers DC, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report—2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1056–1066. doi: 10.1016/j.healun.2019.08.004.
   PubMedGoogle Scholar
• Sponga S, Bonetti A, Ferrara V, et al. Preservation by cold storage vs ex vivo normothermic perfusion of marginal donor hearts: clinical, histopathologic, and ultrastructural features. J Heart Lung Transplant. 2020;39(12):1408–1416. doi: 10.1016/j.healun.2020.08.021.
   PubMed Web of Science ®Google Scholar
• Minasian SM, Galagudza MM, Dmitriev Y V, et al. Preservation of the donor heart: from basic science to clinical studies. Interact Cardiovasc Thorac Surg. 2015;20(4):510–519. doi: 10.1093/icvts/ivu432.
   PubMed Web of Science ®Google Scholar
• Jernryd V, Metzsch C, Andersson B, et al. The influence of ischemia and reperfusion time on outcome in heart transplantation. Clin Transplant. 2020;34(5):e13840. doi: 10.1111/ctr.13840.
   PubMed Web of Science ®Google Scholar
• Lund LH, Khush KK, Cherikh WS, et al. The registry of the international society for heart and lung transplantation: thirty-fourth adult heart transplantation report—2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1037–1046. doi: 10.1016/j.healun.2017.07.019.
   PubMedGoogle Scholar
• Banner NR, Thomas HL, Curnow E, et al. The importance of cold and warm cardiac ischemia for survival after heart transplantation. Transplantation. 2008;86(4):542–547. doi: 10.1097/TP.0b013e31818149b9.
   PubMed Web of Science ®Google Scholar
• Russo MJ, Chen JM, Sorabella RA, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the united network for organ sharing database. J Thorac Cardiovasc Surg. 2007;133(2):554–559. doi: 10.1016/j.jtcvs.2006.09.019.
   PubMed Web of Science ®Google Scholar
• Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation. 2012;93(1):1–10. doi: 10.1097/TP.0b013e31823cab44.
   PubMed Web of Science ®Google Scholar
• Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014;33(4):327–340. doi: 10.1016/j.healun.2014.02.027.
   PubMed Web of Science ®Google Scholar
• Wang L, MacGowan GA, Ali S, et al. Ex situ heart perfusion: the past, the present, and the future. J Heart Lung Transplant. 2021;40(1):69–86. doi: 10.1016/j.healun.2020.10.004.
   PubMed Web of Science ®Google Scholar
• Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the langendorff technique of isolated heart perfusion. J Mol Cell Cardiol. 2011;50(6):940–950. doi: 10.1016/j.yjmcc.2011.02.018.
   PubMed Web of Science ®Google Scholar
• Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion: current clinical experience and the future. Transpl Int. 2015;28(6):634–642. doi: 10.1111/tri.12361.
   PubMed Web of Science ®Google Scholar
• Goldsmith KA, Demiris N, Gooi JH, et al. Life-years gained by reducing donor heart ischemic times. Transplantation. 2009;87(2):243–248. doi: 10.1097/TP.0b013e318190007d.
   PubMed Web of Science ®Google Scholar
• Hassanein WH, Zellos L, Tyrrell TA, et al. Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. J Thorac Cardiovasc Surg. 1998;116(5):821–830. doi: 10.1016/S0022-5223(98)00452-8.
   PubMed Web of Science ®Google Scholar
• Ardehali A, Esmailian F, Deng M, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): A prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577–2584. doi: 10.1016/S0140-6736(15)60261-6.
   PubMed Web of Science ®Google Scholar
• Chan JL, Kobashigawa JA, Reich HJ, et al. Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation. J Heart Lung Transplant. 2017;36(3):258–263. doi: 10.1016/j.healun.2016.08.015.
   PubMed Web of Science ®Google Scholar
• Langmuur SJJ, Amesz JH, Veen KM, et al. Normothermic ex situ heart perfusion with the organ care system for cardiac transplantation: a meta-analysis. Transplantation. Published online 2022;106(9):1745–1753. www.transplantjournal.com doi: 10.1097/TP.0000000000004167.
   PubMed Web of Science ®Google Scholar
• Khush KK, Potena L, Cherikh WS, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: 37th adult heart transplantation report—2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020;39(10):1003–1015. doi: 10.1016/j.healun.2020.07.010.
   PubMedGoogle Scholar
• Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710–1720. doi: 10.1016/j.healun.2005.03.019.
   PubMed Web of Science ®Google Scholar
• Koponen T, Karttunen J, Musialowicz T, et al. Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgery. Br J Anaesth. 2019;122(4):428–436. doi: 10.1016/j.bja.2018.12.019.
   PubMed Web of Science ®Google Scholar
• Sponga S, Benedetti G, de Manna ND, et al. Heart transplant outcomes in patients with mechanical circulatory support: cold storage versus normothermic perfusion organ preservation. Interact Cardiovasc Thorac Surg. 2021;32(3):476–482. doi: 10.1093/icvts/ivaa280.
   Web of Science ®Google Scholar
• García Sáez D, Zych B, Mohite PN, et al. LVAD bridging to heart transplantation With ex vivo allograft preservation shows significantly improved: outcomes: a new standard of care? J Heart Lung Transplantation. 2015;34(4):S95. doi: 10.1016/j.healun.2015.01.252.
   Web of Science ®Google Scholar
• Kaliyev R, Lesbekov T, Bekbossynov S, et al. Heart transplantation of patients with ventricular assist devices: impact of normothermic ex-vivo preservation using organ care system compared with cold storage. J Cardiothorac Surg. 2020;15(1):323. doi: 10.1186/s13019-020-01367-w.
   PubMed Web of Science ®Google Scholar
• Khush KK. Donor selection in the modern era. Ann Cardiothorac Surg. 2018;7(1):126–134. doi: 10.21037/acs.2017.09.09.
   PubMed Web of Science ®Google Scholar
• del Rizzo DF, Menkis AH, Pflugfelder PW, et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant. 1999;18(4):310–319. doi: 10.1016/s1053-2498(98)00059-x.
   PubMed Web of Science ®Google Scholar
• Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int. 2008;21(2):113–125. doi: 10.1111/j.1432-2277.2007.00603.x.
   PubMed Web of Science ®Google Scholar
• Reich HJ, Kobashigawa JA, Aintablian T, et al. Effects of older donor age and cold ischemic time: on long-term outcomes of heart transplantation. Tex Heart Inst J. 2018;45(1):17–22. doi: 10.14503/THIJ-16-6178.
   PubMed Web of Science ®Google Scholar
• Jawitz OK, Devore AD, Patel CB, et al. EXPANDing the donor Pool: quantifying the potential impact of a portable organ-care system for expanded criteria heart donation. J Card Fail. 2021;27(12):1462–1465. doi: 10.1016/j.cardfail.2021.07.018.
   PubMed Web of Science ®Google Scholar
• Hamed A, Tsui S, Huber J, et al. Serum lactate Is a highly sensitive and specific predictor of post cardiac transplant outcomes using the organ care system. J Heart Lung Transplant. 2009;28(2):S71. doi: 10.1016/j.healun.2008.11.025.
   Web of Science ®Google Scholar
• Chew HC, Iyer A, Connellan M, et al. Outcomes of donation after circulatory death heart transplantation in Australia. J Am Coll Cardiol. 2019;73(12):1447–1459. doi: 10.1016/j.jacc.2018.12.067.
   PubMed Web of Science ®Google Scholar
• Kaliyev R, Lesbekov T, Bekbossynov S, et al. Comparison of custodiol vs warm blood cardioplegia and conditioning of donor hearts during transportation with the organ care system. J Card Surg. 2019;34(10):969–975. doi: 10.1111/jocs.14162.
   PubMed Web of Science ®Google Scholar
• White CW, Ambrose E, Müller A, et al. Assessment of donor heart viability during ex vivo heart perfusion. Can J Physiol Pharmacol. 2015;93(10):893–901. doi: 10.1139/cjpp-2014-0474.
   PubMed Web of Science ®Google Scholar
• Ribeiro R, Alvarez J, Gellner B, et al. Contractility versus metabolic cardiac assessment during ex situ heart perfusion: a pre-clinical transplant study. J Heart Lung Transplant. 2019;38(4):S240. doi: 10.1016/j.healun.2019.01.592.
   Web of Science ®Google Scholar
• García Sáez D, Zych B, Sabashnikov A, et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. Ann Thorac Surg. 2014;98(6):2099–2106. doi: 10.1016/j.athoracsur.2014.06.098.
   PubMed Web of Science ®Google Scholar
• Mehta V, Taylor M, Hasan J, et al. Establishing a heart transplant programme using donation after circulatory-determined death donors: a United Kingdom based single-centre experience. Interact Cardiovasc Thorac Surg. 2019;29(3):422–429. doi: 10.1093/icvts/ivz121.
   PubMed Web of Science ®Google Scholar
• Ontario Health. Portable normothermic cardiac perfusion system in donation after cardiocirculatory death: a health technology assessment. Ont Health Technol Assess Ser. 2020;20(3):1–90.
   Google Scholar
• Bishawi M, Roan JN, Milano CA, et al. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy. Sci Rep. 2019;9(1):8029. doi: 10.1038/s41598-019-43737-y.
   PubMedGoogle Scholar
• Nilsson J, Jernryd V, Qin G, et al. A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation. Nat Commun. 2020;11(1):2976. doi: 10.1038/s41467-020-16782-9.
   PubMed Web of Science ®Google Scholar